Home Tags Cancer: Prostate

Tag: Cancer: Prostate

Midlife levels of prostate-specific antigen strongly predict future development of aggressive prostate cancer among black men

Midlife PSA Predicts Aggressive Prostate Cancer in Black Men

Findings suggest potential for a targeted screening approach based on midlife PSA
Patients with prostate cancer receiving care in a Medicare-only setting are more likely to receive guideline-discordant imaging

Guideline-Discordant Prostate Cancer Imaging Up With Medicare

Patients in VA and Medicare group, VA-only group less likely to receive guideline-discordant imaging
Prostate cancer screening with prostate-specific antigen testing is not recommended

PSA Testing Not Recommended for Prostate Cancer Screening

Odds of choosing screening up for men with family history, African descent, low socioeconomic status
The incidence of treatment-emergent small-cell neuroendocrine prostate cancer (t-SCNC) is 17 percent among patients with metastatic castration-resistant prostate cancer

Advanced Prostate Cancer Variant More Common Than Thought

Incidence of tx-emergent small-cell neuroendocrine prostate cancer 17 percent among those with mCRPC
The automated Bone Scan Index is an independent prognostic imaging biomarker of overall survival in metastatic castration-resistant prostate cancer

Automated Bone Scan Index Prognostic for Prostate Cancer

aBSI validated as prognostic biomarker of survival in metastatic castration-resistant prostate cancer
Among U.S. veterans with low-risk prostate cancer

Conservative Management Up for Low-Risk Prostate CA in Veterans

More conservative management and active surveillance utilized at VA hospitals from 2005 to 2015
Enzalutamide treatment can significantly lower risk of metastasis or death in men with rapidly advancing

Enzalutamide Improves Outcomes for Aggressive Prostate Cancer

Treatment led to 71 percent lower risk of metastasis or death compared to placebo
For prostate cancer survivors

Prostate Cancer Treatment Side Effects Linked to Distress

Those with worse emotional distress also report worse urinary, sexual, bowel functions
Overall survival is increased for African-American men with metastatic castration resistant prostate cancer versus Caucasian men treated with docetaxel/prednisone (DP) or a DP-containing regimen

ASCO: Overall Survival Up for African-American Men With mCRPC

Improved survival versus Caucasian men treated with docetaxel/prednisone, DP-containing regimen
Prostate-specific antigen levels three months after radiotherapy are strong markers of prostate cancer outcomes for patients with intermediate- and high-risk disease

PSA Level Three Months After Radiation Tx May Predict Outcome

Findings for men with intermediate- and high-risk prostate cancer